243 related articles for article (PubMed ID: 22186937)
1. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
Hua DK; Howard K; Craig JC; Chapman JR; Wong G
Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
3. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
Wu SW; Chang HR; Lian JD
Nephrol Dial Transplant; 2009 Mar; 24(3):1034-8. PubMed ID: 19059933
[TBL] [Abstract][Full Text] [Related]
4. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
[TBL] [Abstract][Full Text] [Related]
5. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
6. Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy.
Lopez V; Sola E; Gutierrez C; Burgos D; Cabello M; García I; Florez P; Lopez J; Gonzalez-Molina M
Transplant Proc; 2006 Oct; 38(8):2412-3. PubMed ID: 17097952
[TBL] [Abstract][Full Text] [Related]
7. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth F; Pascual M; Erard V; Venetz JP; Nseir G; Meylan P
Antivir Ther; 2008; 13(8):1001-9. PubMed ID: 19195325
[TBL] [Abstract][Full Text] [Related]
8. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
[No Abstract] [Full Text] [Related]
9. BK transplant nephropathy successfully treated with cidofovir.
Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
[No Abstract] [Full Text] [Related]
10. BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
Akioka K; Okamoto M; Ushigome H; Nobori S; Kaihara S; Yoshimura N
Int J Urol; 2008 Apr; 15(4):369-71. PubMed ID: 18380832
[TBL] [Abstract][Full Text] [Related]
11. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.
Johnston O; Jaswal D; Gill JS; Doucette S; Fergusson DA; Knoll GA
Transplantation; 2010 May; 89(9):1057-70. PubMed ID: 20090569
[TBL] [Abstract][Full Text] [Related]
12. Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy.
Midtvedt K; Bjorang O; Letting AS
Clin Transplant; 2007; 21(4):571-3. PubMed ID: 17645722
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir may be deleterious in BK virus-associated nephropathy.
Pallet N; Burgard M; Quamouss O; Rabant M; Bererhi L; Martinez F; Thervet E; Anglicheau D; Noel LH; Rouzioux C; Legendre C
Transplantation; 2010 Jun; 89(12):1542-4. PubMed ID: 20559110
[No Abstract] [Full Text] [Related]
14. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.
Araya CE; Garin EH; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2010 Feb; 14(1):145-50. PubMed ID: 19344337
[TBL] [Abstract][Full Text] [Related]
15. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
16. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
[TBL] [Abstract][Full Text] [Related]
17. Cidofovir may be deleterious in BK virus-associated nephropathy.
Hakeem A; Sharma H; Sharma A
Transplantation; 2011 Jan; 91(2):e11-2; author reply e12. PubMed ID: 21239956
[No Abstract] [Full Text] [Related]
18. [Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
Barrios C; Puig JM; Mir ML
Nefrologia; 2007; 27(6):774-5. PubMed ID: 18336115
[No Abstract] [Full Text] [Related]
19. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.
Wu JK; Harris MT
Ann Pharmacother; 2008 Nov; 42(11):1679-85. PubMed ID: 18957628
[TBL] [Abstract][Full Text] [Related]
20. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2008 Nov; 12(7):790-5. PubMed ID: 18537898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
